What You Should Know:
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced a research collaboration with NVIDIA to accelerate the development and adoption of advanced computer vision solutions in life sciences.Deepcell will incorporate NVIDIA AI into its single cell analysis technology, working collaboratively with NVIDIA to codevelop new uses for generative AI and multimodal applications in cell biology. The
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Digital Health Funding Plunges in 2023, Setting Stage for 2024 Reckoning
What You Should Know:
- The year 2023 saw a stark shift in the digital health funding landscape, according to Rock Health’s annual year-end digital health funding report. Gone were the days of exuberant funding rounds and endless optimism.
- Instead, we witnessed a contraction, with venture capital drying up and startups scrambling to stay afloat. But amidst the turbulence, there were also signs of resilience, innovation, and a necessary course correction.
2023: A Year of Transition and
Read More
Clinical Trial Payments: Optimizing the Path Forward for Site Payments
Escalating competition for clinical trial sites, in tandem with other industry-wide challenges such as changing regulations; a lack of bandwidth and resources; identifying ideal sites and recruiting and retaining patients, are posing significant obstacles for sponsors and site teams within a global study portfolio, particularly in relation to clinical trial payments. Factors such as decentralized clinical trials, inflation and site attrition contribute to inconsistencies and financial confusion,
Read More
Arineta Cardio Imaging Welcomes New CEO Doug Ryan
What You Should Know:
- Arineta Cardio Imaging, a pioneer in cutting-edge cardiovascular imaging solutions, has appointed seasoned medical device leader Doug Ryan as its new CEO.
- Ryan brings 30 years of expertise in building business infrastructure and crafting market strategies for global healthcare giants, poised to propel Arineta to new heights in the fight against cardiovascular disease.
Proven Track Record of Success
Prior to joining Arineta, Ryan held pivotal leadership
Read More
Veracyte Acquires C2i Genomics for $70M, Expanding into Minimal Residual Disease Detection
What You Should Know:
- Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection.
- Under the terms of the agreement, Veracyte will pay $70 million in Veracyte shares at closing, and up to an additional $25 million based on the achievement of future performance milestones over the next two years, payable in Veracyte shares or cash at Veracyte’s election.
- This strategic move positions Veracyte to
Read More
XRHealth Secures $6M to Enhance Immersive VR/AR Experiences
What You Should Know:
- XRHealth, the leading healthcare platform in Spatial Computing, announced today a $6M funding round led by Asabys Partners, with participation from NOVA Prime Fund and XRHealth's existing investors.
- This milestone follows the successful merger with Amelia Virtual Care, solidifying XRHealth's position as the largest extended reality (XR) platform encompassing mental, physical, and occupational health.
VR/AR Meets Patient Needs
XRHealth's platform leverages
Read More
Quest Diagnostics & Ultima Team Up to Tackle MRD & Whole Genome Sequencing
What You Should Know:
Ultima Genomics, a developer of a revolutionary new ultra-high throughput sequencing architecture, and Quest Diagnostics, the nation’s leading provider of diagnostic information services, today announced a collaboration involving Ultima’s next generation sequencing (NGS) technology in oncology and other clinical areas.
Expanding Horizons in Cost-Effective Whole Genome Sequencing
The collaboration aims to enhance patient access, affordability, and
Read More
Say Goodbye to Tremors: FDA Greenlights Medtronic’s Percept RC with BrainSense
What You Should Know:
Medtronic, a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system.The rechargeable neurostimulator is the latest innovation in the Medtronic Percept™ family, which includes the Percept™ PC neurostimulator, BrainSense™ technology, and SenSight™ directional leads. The Percept™ family is the only sensing-enabled DBS system on the market, allowing the physician to
Read More
Butterfly iQ3 Takes Flight: Next-Gen Handheld Ultrasound Cleared by FDA
What You Should Know:
Butterfly Network, Inc. (“Butterfly”), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced the FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3.The new device is the company’s third iteration of the world’s first semiconductor-based single-probe, whole-body ultrasound system. Butterfly iQ3 features a brand-new
Read More
Caris & Flatiron Team Up: Next-Level RWD Supercharges Cancer Drug Discovery
What You Should Know:
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionise healthcare and improve the human condition using molecular science and AI, and Flatiron Health, a leading health-tech company transforming evidence generation through an engaged care network, oncology-specific expertise, and fit-for-purpose scientific methods and tools, today
Read More
